IGHE and allergic disease: Thus, prevention of IgE binding to FcεRI on these cells is an effective therapy for allergic disease.Therefore, when developing anti-allergic pharmaceutical drugs, stabilisation of mast cells and suppression of degranulation should be the major targets.